To translate these observations to in vivo models of CRC, we engrafted mice with wild-type (WT) or hepcidin-silenced CT26 cells and observed that hepcidin deficiency reduced the growth of tumors. The gene discussed is HAMP; the disease is colorectal carcinoma.